FOCL EDAP TMS SA
Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1041934 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin44.4%
Operating margin-31.8%
Net margin-42.8%
FCF margin—
EBITDA margin-27.4%
Returns
ROE-129.2%
ROA—
ROIC (approx.)-176.5%
Asset turnover—
Leverage & solvency
Liabilities / assets67.5%
Debt / equity0.99x
Current ratio2.63x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.35x
Accruals ratio—
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $9.83M | $13.20M | $17.81M | $46.69M | $7.83M | $9.51M | $14.27M |
| Cost of revenue | $4.78M | $5.87M | $9.67M | $28.36M | $4.18M | $4.65M | $8.27M |
| Gross profit | $5.05M | $7.34M | $8.15M | $18.33M | $3.65M | $4.86M | $5.99M |
| R&D expense | $2.46M | $2.32M | $2.60M | $2.71M | $2.30M | $2.29M | $2.58M |
| SG&A expense | $4.46M | $5.52M | $5.79M | $6.84M | $3.83M | $3.90M | $3.65M |
| Operating income | -$7.78M | -$8.03M | -$7.37M | -$4.66M | -$6.67M | -$6.62M | -$6.31M |
| Pretax income | -$5.27M | -$14.40M | -$8.94M | -$8.05M | -$6.64M | -$6.34M | -$7.30M |
| Income tax | $15,000 | $8,000 | $145,000 | $399,000 | $16,000 | $14,000 | $144,000 |
| Net income | -$4.46M | -$14.49M | -$9.08M | -$9.46M | -$5.94M | -$6.41M | -$7.44M |
| EBITDA | -$6.78M | -$7.03M | -$6.47M | -$3.75M | -$5.77M | -$5.78M | -$5.56M |
| EPS (basic) | -0.10 | -0.39 | -0.24 | — | -0.16 | -0.17 | -0.20 |
| EPS (diluted) | -0.10 | -0.39 | -0.24 | — | -0.16 | -0.17 | -0.20 |
| Weighted avg. shares (diluted) | 42.63M | 37.53M | 37.48M | — | 37.44M | 37.42M | 37.39M |
| Balance sheet | |||||||
| Cash & equivalents | $56.27M | $21.54M | $15.01M | $20.45M | $12.41M | $19.06M | $24.69M |
| Short-term investments | — | — | — | $0 | — | — | — |
| Receivables | $10.18M | $10.06M | $19.65M | $14.95M | — | — | — |
| Inventory | $8.33M | $8.25M | $13.33M | $7.77M | — | — | — |
| Current assets | $94.78M | $59.02M | $50.36M | $57.16M | — | — | — |
| PP&E, net | $9.05M | $8.63M | $10.20M | $8.79M | — | — | — |
| Goodwill | $732,000 | $735,000 | $2.77M | $757,000 | $757,000 | — | $2.61M |
| Intangibles | $1.82M | $1.77M | $1.72M | $1.79M | — | — | — |
| Total assets | $110.72M | $74.55M | $72.06M | $79.00M | — | — | $81.09M |
| Current liabilities | $36.07M | $36.85M | $37.51M | $37.14M | — | — | — |
| Short-term debt | $338,000 | $848,000 | $1.46M | $2.08M | — | — | — |
| Long-term debt | $35.23M | $37.20M | $17.60M | $15.90M | — | — | — |
| Total debt | $35.57M | $38.05M | $19.06M | $17.98M | — | — | — |
| Total liabilities | $74.78M | $77.77M | $61.96M | $59.58M | — | — | — |
| Shareholders' equity | $35.94M | -$3.23M | $10.10M | $19.41M | $22.08M | $27.45M | $37.27M |
| Net debt | -$20.70M | $16.50M | $4.05M | -$2.47M | — | — | — |
| Shares outstanding | 47.22M | 37.53M | 37.48M | 37.48M | — | — | — |
| Cash flow statement | |||||||
| Operating cash flow | -$4.02M | -$3.69M | -$2.97M | -$2.45M | -$3.91M | -$4.71M | -$5.34M |
| Investing cash flow | -$1.34M | -$1.26M | -$754,000 | -$1.71M | -$1.08M | -$1.61M | -$1.30M |
| Financing cash flow | $40.30M | $11.77M | -$1.37M | $11.46M | -$1.65M | $56,000 | -$1.25M |
| Depreciation & amortization | $998,000 | $1.01M | $896,000 | $911,000 | $897,000 | $846,000 | $753,000 |
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.